Bio-Rad Laboratories stockBIO
Bio-Rad Laboratories trades at $369.00, 6.9% below its 52-week high (Aug 27, 2026). The price is below its 50-day but above its 200-day average: a pullback within an uptrend. +21.8% year to date, +19.0% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 18, 2027.
Ratings, candles, signals and the screener for BIO — after you log in
Open the terminalFrequently asked questions about Bio-Rad Laboratories
What is the Bio-Rad Laboratories stock price?
At the close on Nov 5, 2026: $369.00 (−2.89% on the day). 52-week high: $396.23 on Aug 27, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Bio-Rad Laboratories report earnings?
The next quarterly report is on Feb 18, 2027. Last quarter, earnings per share changed +17% year over year, revenue +1%.
Does Bio-Rad Laboratories pay dividends?
No, Bio-Rad Laboratories does not pay dividends.
Where does Bio-Rad Laboratories trade and how to buy it?
Ticker BIO, exchange NYSE. You can buy it through a broker with access to US exchanges.
Should I buy Bio-Rad Laboratories now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for BIO are in the terminal after you log in.